177 related articles for article (PubMed ID: 12734343)
1. Mechanisms of accelerated immune-mediated diabetes resulting from islet beta cell expression of a Fas ligand transgene.
Silva DG; Petrovsky N; Socha L; Slattery R; Gatenby P; Charlton B
J Immunol; 2003 May; 170(10):4996-5002. PubMed ID: 12734343
[TBL] [Abstract][Full Text] [Related]
2. Evidence that beta cell death in the nonobese diabetic mouse is Fas independent.
Thomas HE; Darwiche R; Corbett JA; Kay TW
J Immunol; 1999 Aug; 163(3):1562-9. PubMed ID: 10415060
[TBL] [Abstract][Full Text] [Related]
3. Beta-cell destruction in NOD mice correlates with Fas (CD95) expression on beta-cells and proinflammatory cytokine expression in islets.
Suarez-Pinzon W; Sorensen O; Bleackley RC; Elliott JF; Rajotte RV; Rabinovitch A
Diabetes; 1999 Jan; 48(1):21-8. PubMed ID: 9892218
[TBL] [Abstract][Full Text] [Related]
4. Significant role for Fas in the pathogenesis of autoimmune diabetes.
Su X; Hu Q; Kristan JM; Costa C; Shen Y; Gero D; Matis LA; Wang Y
J Immunol; 2000 Mar; 164(5):2523-32. PubMed ID: 10679090
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of autoimmune diabetes by Fas ligand: the paradox is solved.
Kim S; Kim KA; Hwang DY; Lee TH; Kayagaki N; Yagita H; Lee MS
J Immunol; 2000 Mar; 164(6):2931-6. PubMed ID: 10706679
[TBL] [Abstract][Full Text] [Related]
6. Islet-specific expression of IL-10 promotes diabetes in nonobese diabetic mice independent of Fas, perforin, TNF receptor-1, and TNF receptor-2 molecules.
Balasa B; Van Gunst K; Jung N; Balakrishna D; Santamaria P; Hanafusa T; Itoh N; Sarvetnick N
J Immunol; 2000 Sep; 165(5):2841-9. PubMed ID: 10946317
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis of pancreatic beta-cells detected in accelerated diabetes of NOD mice: no role of Fas-Fas ligand interaction in autoimmune diabetes.
Kim YH; Kim S; Kim KA; Yagita H; Kayagaki N; Kim KW; Lee MS
Eur J Immunol; 1999 Feb; 29(2):455-65. PubMed ID: 10064061
[TBL] [Abstract][Full Text] [Related]
8. The role of Fas in autoimmune diabetes.
Chervonsky AV; Wang Y; Wong FS; Visintin I; Flavell RA; Janeway CA; Matis LA
Cell; 1997 Apr; 89(1):17-24. PubMed ID: 9094710
[TBL] [Abstract][Full Text] [Related]
9. A mechanism for IL-10-mediated diabetes in the nonobese diabetic (NOD) mouse: ICAM-1 deficiency blocks accelerated diabetes.
Balasa B; La Cava A; Van Gunst K; Mocnik L; Balakrishna D; Nguyen N; Tucker L; Sarvetnick N
J Immunol; 2000 Dec; 165(12):7330-7. PubMed ID: 11120869
[TBL] [Abstract][Full Text] [Related]
10. The role of CD8+ cells, cell degeneration, and Fas ligand in insulitis after intraperitoneal transfer of NOD splenocytes.
Sainio-Pöllänen S; Liukas A; Pöllänen P; Simell O
Pancreas; 1999 Apr; 18(3):282-93. PubMed ID: 10206487
[TBL] [Abstract][Full Text] [Related]
11. IFN-gamma/TNF-alpha synergism as the final effector in autoimmune diabetes: a key role for STAT1/IFN regulatory factor-1 pathway in pancreatic beta cell death.
Suk K; Kim S; Kim YH; Kim KA; Chang I; Yagita H; Shong M; Lee MS
J Immunol; 2001 Apr; 166(7):4481-9. PubMed ID: 11254704
[TBL] [Abstract][Full Text] [Related]
12. Beta-cell apoptosis in an accelerated model of autoimmune diabetes.
Augstein P; Stephens LA; Allison J; Elefanty AG; Ekberg M; Kay TW; Harrison LC
Mol Med; 1998 Aug; 4(8):495-501. PubMed ID: 9742505
[TBL] [Abstract][Full Text] [Related]
13. TNF receptor 1-dependent beta cell toxicity as an effector pathway in autoimmune diabetes.
Kägi D; Ho A; Odermatt B; Zakarian A; Ohashi PS; Mak TW
J Immunol; 1999 Apr; 162(8):4598-605. PubMed ID: 10201999
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic expression of B7 co-stimulatory molecules in the non-obese diabetic mouse.
Stephens LA; Kay TW
Int Immunol; 1995 Dec; 7(12):1885-95. PubMed ID: 8746558
[TBL] [Abstract][Full Text] [Related]
15. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A
J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666
[TBL] [Abstract][Full Text] [Related]
16. IL-1alpha, IL-1beta, and IFN-gamma mark beta cells for Fas-dependent destruction by diabetogenic CD4(+) T lymphocytes.
Amrani A; Verdaguer J; Thiessen S; Bou S; Santamaria P
J Clin Invest; 2000 Feb; 105(4):459-68. PubMed ID: 10683375
[TBL] [Abstract][Full Text] [Related]
17. Intrathymic islet cell transplantation reduces beta-cell autoimmunity and prevents diabetes in NOD/Lt mice.
Gerling IC; Serreze DV; Christianson SW; Leiter EH
Diabetes; 1992 Dec; 41(12):1672-6. PubMed ID: 1446808
[TBL] [Abstract][Full Text] [Related]
18. Local expression of transgene encoded TNF alpha in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells.
Grewal IS; Grewal KD; Wong FS; Picarella DE; Janeway CA; Flavell RA
J Exp Med; 1996 Nov; 184(5):1963-74. PubMed ID: 8920883
[TBL] [Abstract][Full Text] [Related]
19. Fas is expressed in murine pancreatic islet cells and an insulinoma cell line but does not mediate their apoptosis in vitro.
Lee MS; Kim S; Chung JH; Lee MK; Kim KW
Autoimmunity; 1999; 29(3):189-99. PubMed ID: 10433099
[TBL] [Abstract][Full Text] [Related]
20. Thymic and postthymic regulation of diabetogenic CD8 T cell development in TCR transgenic nonobese diabetic (NOD) mice.
Kanagawa O; Shimizu J; Vaupel BA
J Immunol; 2000 May; 164(10):5466-73. PubMed ID: 10799914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]